The Australian Therapeutic Goods Administration (TGA) has introduced changes to permit the use of COVID-19 rapid antigen self-testing and...

DLA Piper’s Life Sciences team has updated our recent vaccine guide for employers. The changes include the additions of Sweden and...

For decades, scientists have studied the seemingly endless possibilities of custom-made messenger RNA, or mRNA. Kathy Fernando, Head Vice...

Our report 'The COVID-19 pandemic and the pharmaceutical and medical sector in Poland' is the first that brings together the...

As the scientific response to the COVID-19 pandemic develops, many employers are considering what their approach should be to the issues...

The 2021-2022 Australian Federal Budget was unveiled last night (11 May 2021). Deemed the ‘COVID-19 Recovery Budget’, it includes a...

As countries in the European Union (EU) take baby steps towards reopening businesses and ramp up COVID-19 vaccination, the pandemic and...

The European Commission is currently working out a Digital Green Certificate mechanism with the eHealth Network. The setting-up of this...

The global outlook for M&A in the digital health and particularly the telehealth sector has never been brighter than today.

Portugal published Law no. 4-C/2021, which transposes the Directive (EU) 2020/2020 from the 7th of December 2020, as regards temporary...

At a time where drug makers are taking action to develop modified versions of their vaccines in order to address the evolving variants of...

On Thursday evening (28 January 2021) a new Government Decree (Nr. 19/2021) was published in the Official Journal of Hungary amending the...

As the medical and healthcare sectors remain firmly focused on tackling the many and ongoing challenges of COVID-19, the Australian...

After weeks of intensive collaboration and inspiring contributions from more than 100 Life Sciences enthusiasts across five continents,...